Business
Median Technologies to Present Scientific Posters on eyonis® LCS in Two Major Health Conferences in North America in May 2025
SOPHIA ANTIPOLIS, France, May 12, 2025--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced today that the Company will attend two major health conferences and present posters
About this update from Median Technologies
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1240,"height":461,"url":"https://media.zenfs.com/en/business-wire.com/d1479f22eb6d8a628fdf2a3becea7b48"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ERAsdh5bBDstKq2W5ShgzA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM1NztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d1479f22eb6d8a628fdf2a3becea7b48","width":960,"height":357},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/v7L8E6F0BKx.P4BOlvHmGg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04OTI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/d1479f22eb6d8a628fdf2a3becea7b48","width":1200,"height":446}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Projected economic benefits of using AI-powered detection/diagnostic Software as a Medical Device, like eyonis® LCS, will be presented at ISPOR 2025, the annual conference of the leading professional society for health economics and outcomes research","length":250,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Positive eyonis® LCS’ REALITY pivotal data to be presented at American Thoracic Society (ATS) 2025 International Conference","length":123,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The eyonis® team will be hosting interested parties at booth #1662 during ATS 2025","length":82,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":455,"olType":false},{"type":"text","content":"SOPHIA ANTIPOLIS, France, May 12, 2025--(BUSINESS WIRE)--Regulatory News:","length":73,"tagName":"p"},{"type":"text","content":"Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced today that the Company will attend two major health conferences and present posters on its Software as a Medical Device (SaMD) eyonis® LCS, for Lung Cancer Screening.","length":546,"tagName":"p"},{"type":"text","content":"The eyonis® LCS SaMD is an AI-powered Software as a Medical Device (SaMD) to detect and diagnose (CADe/CADx) lung ca...